Trials / Unknown
UnknownNCT05273762
Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever
Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever: Efficacy and Safety
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is focused on investigating the efficacy and safety of the FlowTriever device to treat low-risk submassive pulmonary embolism.
Detailed description
In this study, patients that present with low-risk submassive pulmonary embolism with hemodynamic stability and with either positivity of cardiac biomarkers, or radiographic or echocardiographic evidence of right ventricular strain will be assigned to be treated with mechanical thrombectomy, which includes conscious sedation, via FlowTriever.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FlowTriever | Mechanical thrombectomy for pulmonary embolism |
Timeline
- Start date
- 2022-01-25
- Primary completion
- 2024-07-01
- Completion
- 2024-07-25
- First posted
- 2022-03-10
- Last updated
- 2023-12-28
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05273762. Inclusion in this directory is not an endorsement.